NCT00248963View on ClinicalTrials.gov

Study Evaluating Levonorgestrel and Ethinyl Estradiol in Oral Contraception

PHASE3CompletedINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

Not specified

Study Completion Date

October 31, 2004

Conditions
Oral Contraceptive
Interventions
DRUG

Levonorgestrel 90 mg and Ethinyl Estradiol 20 mg

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY